Which condition is Daliresp specifically contraindicated for?

Daliresp, or roflumilast, is specifically contraindicated in patients with a milk protein allergy. This is due to the formulation of the medication which may contain components derived from milk, posing a risk of allergic reactions in susceptible individuals. It is important for healthcare providers to be aware of any allergies a patient may have, as it can significantly impact their safety and the appropriateness of a medication.

In contrast, Daliresp is indicated for chronic obstructive pulmonary disease (COPD) and chronic bronchitis to help reduce the risk of exacerbations and improve lung function. Asthma is also not a direct contraindication, but the medication is not typically used for asthma treatment. Understanding the specific contraindications and indications of medications helps ensure patient safety and effective treatment strategies.